Cytosorbents Corp (CTSO) income statement
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30
$5.57+1.05 (+23.12%)
Close on Nov 18, 2026Market cap $349.72MP/E –Yield –
Cytosorbents Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 71.6%
- Operating margin
- -34.7%
- Net margin
- -48.9%
- Return on equity, FY2025
- -96.4%
Financial strength
- Current ratio
- 0.66
- Debt to equity
- -22.96
- Debt to assets
- 45.4%
- Cash to current liabilities
- 18.4%
Valuation
- P/E ratio
- –
- Price to sales
- 9.40
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?